Lipozyt Marker
Bremen
About Lipozyt Marker
Lipozyt Marker provides oral anti-diabetic therapy. They offer a test kit that conducts mRNA analysis of the subcutaneous fatty tissue in combination with classic blood tests to determine individual causes of diabetes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $227.1K
- Last round: Equity Crowdfunding (May 2020)
- Website: lipozyt-marker.comde
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/lipozyt-marker-221528 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.